eISSN: 2500-7106 / ISSN: 0123-2576
Register
Login
Medicinay Laboratorio
2025, Volume: 29, Issue:3-4 : 73-77 doi: 10.36384/01232576.727
Research Article
Evaluation of Drain vs No-Drain Policy in Modified Radical Mastectomy
 ,
1
Microbiólogo y Bioanalista, Estudiante de Maestría. Grupo Reproducción, Grupo Centauro, Investigación Universitaria, Universidad de Antioquia. Medellín, Colombi
2
Médico especialista en Ginecología y Obstetricia. Ginecólogo y Mastólogo, Clínica Las Américas. Medellín, Colombi
Received
Oct. 12, 2025
Revised
Oct. 26, 2025
Accepted
Nov. 16, 2025
Published
Nov. 29, 2025
Abstract
Abstract Introduction: Modified radical mastectomy (MRM) remains a standard surgical procedure for operable breast carcinoma. The use of postoperative drains has traditionally been recommended to reduce seroma formation and other wound-related complications. However, recent evidence questions the necessity of routine drainage. This study evaluates outcomes of drain versus no-drain policy in MRM.Materials and Methods:A prospective comparative study was conducted among 120 patients undergoing MRM for carcinoma breast. Patients were randomly divided into two groups: Drain group (n=60) and No-drain group (n=60). Primary outcomes included seroma formation, wound infection, flap necrosis, hematoma, duration of hospital stay, and need for intervention. Statistical analysis was performed using Chi-square and independent t-test.Results:Seroma formation was higher in the no-drain group (30%) compared to the drain group (15%) (p<0.05). However, duration of hospital stay was significantly shorter in the no-drain group (3.2±0.8 days vs 6.5±1.1 days). No significant difference was observed in wound infection, flap necrosis, or hematoma rates.Conclusion:The no-drain policy is associated with shorter hospital stay without significant increase in major complications, though seroma incidence is moderately higher. Selective drain use may be considered.
Keywords
License
Copyright (c) Medicinay Laboratorio
Creative Commons Attribution License Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
Medicinay Laboratorio open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Recommended Articles
Lupus eritematoso sistémico
211-223
PDF
Impact of Severe Pre-eclampsia and Eclampsia on Fetomaternal Outcomes: A retrospective study
14-17
PDF
The role of the microbiology laboratory in clinical practice
295-296
PDF
Balance of the last three years: Adaptation and evolution towards a new stage
11-12
PDF
Medicinay Laboratorio journal thumbnail
Volume: 29, Issue:3-4
Citations
51 Views
297 Downloads
Share this article
Editora Médica Colombiana SA / Universidad de Antioquia
Certified Continuing Medical Education Program (PEMCC)
Email: submission@medicinaylaboratorio.com
Carrera 43C #5-33 Medellín, Colombia 050022
DOI: https://doi.org/10.36384/issn.0123-2576
Open Access Publication
Magazone managed by Biteca